US appeals court upholds Prevacid ruling against Teva
This article was originally published in Scrip
Executive Summary
A US appeals court has ruled in favour of Takedain an ongoing patent dispute, thus preventing Teva Pharmaceutical Industriesfrom launching its generic version of Prevacid (lansoprazole) delayed-release capsules until November 2009.